Johnson & Johnson Continues To Ride The Success Of Its Immunology & Oncology Drugs
Johnson & Johnson ( JNJ ) posted a moderate growth of 3% in Q3 2013 amid a stable healthcare environment, …read more
Intel’s Q3 Earnings: Strong Data Center Growth & New Products Instill Hope
PC microprocessor manufacturer Intel ( INTC ) is executing well in a tough market environment, posting modest growth in its …read more
Coca-Cola Delivers Balanced Growth From Its Diversified Portfolio
The Coca Cola Company’s ( KO ) third quarter earnings came out largely on expected lines, with a moderate 2% …read more
Can Discover Financial (DFS) Keep Earnings Streak Alive? – Analyst Blog
We expect the direct banking and payment services company Discover Financial Services Inc. ( DFS ) to beat expectations when …read more
AIG Upped to Outperform – Analyst Blog
We have upgraded life and property insurer American International Group Inc. ( AIG ) to Outperform based on …read more
Will Alliance Data Continue to Gain Strength? – Analyst Blog
Alliance Data Systems Corporation ( ADS ) has been on an uptrend, reflecting investor enthusiasm so far. Shares improved about …read more
Update on Sanofi’s Fabrazyme Manufacturing – Analyst Blog
While the Genzyme acquisition has allowed Sanofi ( SNY ) to increase its presence in the biopharmaceutical market, we note …read more
Exar’s Next-Gen Coprocessors Fail to Cheer – Analyst Blog
Analog mixed signal components supplier Exar Corporation ( EXAR ) has been constantly upgrading its product portfolio with product launches. …read more
Altera Extends Product Portfolio – Analyst Blog
Semiconductor chip giant Altera Corporation ( ALTR ) recently announced the addition of five 28 nm Cyclone V FPGA development …read more
Alcoa Suspends Production at Saudi Smelter – Analyst Blog
Aluminum giant Alcoa Inc. ( AA ) announced that it has temporarily halted production at one of two potlines at …read more